4.5 Article

Small molecule approaches to treat autoimmune and inflammatory diseases (Part II): Nucleic acid sensing antagonists and inhibitors

Journal

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Volume 44, Issue -, Pages -

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2021.128101

Keywords

Autoimmune and inflammatory diseases; Innate immunity; Nucleic acid; Small molecule antagonists; Inhibitors

Ask authors/readers for more resources

Aberrant activation of nucleic acid sensing pathways is closely associated with autoimmune and inflammatory diseases, making research on small molecule antagonists or inhibitors of these pathways crucial.
Nucleic acid sensing pathways play an important role in the innate immune system, protecting hosts against infections. However, a large body of evidence supports a close association between aberrant activation of those pathways and autoimmune and inflammatory diseases. Part II of the digest series on small molecule approaches to autoimmune and inflammatory diseases concentrates on recent advances with respect to small molecule antagonists or inhibitors of the nucleic acid sensing pathways, including endosomal TLRs, NLRP3 inflammasome and cGAS-STING.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available